Trudy Vanhove is a venture partner at Longitude Capital who brings an unusually complete academic background—MD and PhD in Pharmacology from KU Leuven, clinical pharmacology fellowship at Stanford, and MBA—combined with hands-on experience as a biopharmaceutical executive across companies from Abbott to Jazz Pharmaceuticals. She evaluates investments through an operator's lens, assessing whether programs are scientifically sound, address clear unmet medical needs, can realistically enroll patients in trials, and will be reimbursable—giving equal weight to science, market potential, and operational feasibility rather than approaching deals from a traditional finance background.